ArticleEuropean heart journal. Case reports2026
Optimal timing of mechanical circulatory support in rapidly progressive fulminant myocarditis: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fulminant myocarditis (FM) can rapidly progress to cardiogenic shock and cardiac arrest; however, the optimal timing of mechanical circulatory support (MCS) initiation remains uncertain, particularly regarding patients with rapidly progressive disease at risk of sudden haemodynamic deterioration. Case summary: A 57-year-old Asian man presented with chest pain following flu-like symptoms. On admission, he was hypotensive with elevated cardiac biomarkers and global left ventricular hypokinesia with a left ventricular ejection fraction of approximately 40%. Acute coronary syndrome was excluded by emergent coronary angiography. During evaluation in the cardiac catheterization laboratory, sustained ventricular tachycardia, rapidly worsening haemodynamic, and early signs of end-organ hypoperfusion indicated progressive cardiogenic shock with a high risk of further deterioration. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was therefore initiated based on these evolving clinical findings. Despite initial stabilization, the patient developed complete atrioventricular block followed by pulseless electrical activity, resulting in cardiac arrest within approximately 4 h of presentation. Combined support with VA-ECMO and Impella CP was established. Cardiac function gradually recovered, and the patient was successfully weaned from MCS. Endomyocardial biopsy confirmed lymphocytic myocarditis. Discussion: This case highlights the clinical importance of determining the optimal timing of MCS initiation in patients with suspected FM at high risk of rapid deterioration. Early support prior to further haemodynamic deterioration may stabilize circulation, facilitate diagnostic procedures, and provide a bridge to myocardial recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.